These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7014973)

  • 21. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.
    Aldwell FE; Cross ML; Fitzpatrick CE; Lambeth MR; de Lisle GW; Buddle BM
    Vaccine; 2006 Mar; 24(12):2071-8. PubMed ID: 16332403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discovery of immunostimulatory DNA sequence.
    Yamamoto S; Yamamoto T; Tokunaga T
    Springer Semin Immunopathol; 2000; 22(1-2):11-9. PubMed ID: 10944796
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of immunobiological properties of specific immunomodulators of the adjuvant type in experimental tuberculosis].
    Gorelova LA; Zemskova ZS; Panasek IA; Nekrasov AV; Puchkova NG; Moroz AM; Romanova RIu
    Probl Tuberk; 1996; (3):46-7. PubMed ID: 8754882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [beta-1, 3 glucan as an immunopotentiator against experimental tuberculous infection in mice (author's transl)].
    Kanai K; Kondo E
    Kekkaku; 1980 Aug; 55(8):371-4. PubMed ID: 7420811
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experimental study of antitumor effect of an extract derived from Zhu-ling (Polyporus umbelltus) (author's transl)].
    Zhonghua Zhong Liu Za Zhi; 1981 May; 3(2):106-9. PubMed ID: 7307888
    [No Abstract]   [Full Text] [Related]  

  • 26. Bacillus Calmette-Guerin, Mycobacterium bovis, as an immunomodulator in atopic diseases.
    Barlan I; Bahceciler NN; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2006 May; 26(2):365-77, ix. PubMed ID: 16701150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of IFN-gamma producing cells correlates with adjuvant enhancement of bacille Calmette-Guèrin induced protection against Mycobacterium bovis.
    Logan KE; Chambers MA; Hewinson RG; Hogarth PJ
    Vaccine; 2005 Dec; 23(48-49):5526-32. PubMed ID: 16105710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Disseminated infection due to Mycobacterium bovis alter intravesical instillation of BCG].
    de la Iglesia Fanjul I; de Castro Losa MR; Mourad F; Bajo Franco T
    An Med Interna; 2007 Oct; 24(10):514-5. PubMed ID: 18333323
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement of cell-mediated immune response in mice by whole HIV-1 gag in Mycobacterium bovis BCG as a live vaccine candidate.
    Promkhatkaew D; Pinyosukhee N; Thongdeejaroen W; Sutthent R; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):113-22. PubMed ID: 19323043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis.
    Andersen CS; Dietrich J; Agger EM; Lycke NY; Lövgren K; Andersen P
    Infect Immun; 2007 Jan; 75(1):408-16. PubMed ID: 17074845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mode of action of kanamycin on Mycobacterium bovis, BCG (author's transl)].
    Oizumi K; Kumano N; Konno K; Oka S
    Kekkaku; 1974 Jan; 49(1):9-14. PubMed ID: 4597147
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
    Joraku A; Homhuan A; Kawai K; Yamamoto T; Miyazaki J; Kogure K; Yano I; Harashima H; Akaza H
    BJU Int; 2009 Mar; 103(5):686-93. PubMed ID: 19040525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of cattle with Mycobacterium bovis BCG by a combination of systemic and oral routes.
    Buddle BM; Denis M; Aldwell FE; Martin Vordermeier H; Glyn Hewinson R; Neil Wedlock D
    Tuberculosis (Edinb); 2008 Nov; 88(6):595-600. PubMed ID: 18439875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initial characterization of an antineoplastic, polysaccharide-rich extract of Mycobacterium bovis BCG, Tice substrain.
    Lou Y; Klegerman ME; Muhammad A; Dai X; Groves MJ
    Anticancer Res; 1994; 14(4A):1469-75. PubMed ID: 7979173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stability and immunogenicity of the fresh BCG vaccine applied with a new multiple puncture device (author's transl)].
    Gheorghiu M; Lagranderie M; Bredèche M
    Ann Microbiol (Paris); 1981; 132(3):307-18. PubMed ID: 7027870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The mechanism of immunosuppression in tumor-bearing mice--different susceptibility of various immune responses to immunosuppression and macrophage series as targets for immunosuppression (author's transl)].
    Okuda S
    Fukuoka Igaku Zasshi; 1981 Dec; 72(12):687-702. PubMed ID: 7341394
    [No Abstract]   [Full Text] [Related]  

  • 39. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM
    Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.